In the limited time of an office visit, how can a primary care physician make the case to parents that their child should be vaccinated? During National Infant Immunization Week, a Mayo Clinic vaccine expert and a pediatrician offer suggestions for refuting three of the most common myths about child vaccine safety. Their article, The Clinician's Guide to the Anti-Vaccinationists' Galaxy, is published online this month in the journal Human Immunology.
"Thousands of children are at increased risk because of under-vaccination, and outbreaks of highly transmissible diseases have occurred" says lead author Gregory Poland, MD, Mayo Clinic vaccinologist. "Primary care physicians have less time than most to explain the scientific case for vaccination. This article gives them the background and tools to debunk some of the major myths."
Poland and Mayo pediatrician Robert Jacobson, MD, review the three immunity-related misconceptions that they say "fuel patient and parental concerns, questions and fears about vaccines." Those myths are:
- Babies' systems aren't ready for the number of vaccines given today.
- Vaccines can cause autoimmune diseases.
- Natural immunity is safer and better.
The Mayo experts explain that the number of active molecules in infant vaccines is far lower than ever before, so while vaccines are not only safe, each child is receiving a fraction of actual antigen compared to children in the past. Among other evidence, they point to a recent review of 1,200 articles by the Institute of Medicine that failed to find any autoimmune side effect from vaccines. They make the point that there is either no impact or that any relation to autoimmune conditions is not causative. Finally, they make the case that while natural immunity does protect as well, the risk of illness and death is far higher than with a vaccine.
The article also includes background on the anti-vaccine movement and outlines the harm it has done by spreading inaccurate information.
"We want to offer a user-friendly guide for doctors, but also issue a call to action," Poland says. "We can now show that children have died because of under-vaccination and that diseases have spread needlessly because of this trend."
Poland says lack of vaccination has put many children at risk for diseases that are avoidable, including whooping cough and measles. He emphasized that the risk of death for measles is three in 1,000 without vaccination, while the risk of death from the measles vaccination is zero.
Poland is the chairman of a safety evaluation committee for investigational vaccine trials being conducted by Merck Research Laboratories. Poland offers consultative advice on new vaccine development to Merck & Co., Inc., Avianax, Theraclone Sciences (formally Spaltudaq Corporation), MedImmune LLC, Liquidia Technologies, Inc., Emergent BioSolutions, Novavax, Dynavax, EMD Serono, Inc., Novartis Vaccines and Therapeutics and PAXVAX, Inc.
Jacobson is a member of a safety review committee for a post-licensure study funded by Merck & Co. concerning the safety of a human papillomavirus vaccine. He is a member of a data monitoring committee for an investigational vaccine trial funded by Merck & Co. He is principal investigator for two studies, including one funded by Novartis International for its licensed meningococcal conjugate vaccine and one funded by Pfizer, Inc. for its licensed pneumococcal conjugate vaccine.
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.